Two U.S. Food and Drug Administration (FDA) advisory committees voted on January 23rd to recommend that the regulatory agency approve GlaxoSmithKline’s petition to sell a half-dose version of the diet drug Xenical (orlistat) without a prescription.

The FDA advisory committees, following …

The new chief executive of Sanofi Aventis, Gérard Le Fur, says the company needs to improve its ‘communication,’ but not by disclosing why diet drug Acomplia (rimonabant) has been stalled for more than a year at the U.S. Food and …

The U.S. Food and Drug Administration (FDA) staff has raised a variety of warning flags in advance of an advisory committee meeting set for Jan. 23rd to consider GlaxoSmithKline’s petition to sell a half-dose version of the diet drug Xenical …

A Virginia Tech student newspaper has gotten quite a bit of attention in the past two days with an article on Acomplia suggesting that while a pill that combats obesity and potentially decreases the risk of heart complications sounds like …

While diet drug Acomplia (rimonabant) has been approved for sale in Mexico since Nov. 9th, the diet pill does not seem to be generally available yet in Mexican pharmacies.

A survey of some of Mexico’s largest pharmacies

…